X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1092) 1092
Conference Proceeding (1010) 1010
Publication (42) 42
Patent (27) 27
Book Review (19) 19
Book Chapter (8) 8
Book / eBook (4) 4
Dissertation (3) 3
Data Set (2) 2
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (759) 759
oncology (691) 691
humans (530) 530
male (286) 286
adult (260) 260
female (255) 255
middle aged (249) 249
transplantation (172) 172
index medicus (156) 156
aged (151) 151
immunology (132) 132
treatment outcome (97) 97
chemotherapy (90) 90
antineoplastic combined chemotherapy protocols - therapeutic use (81) 81
adolescent (78) 78
cancer (73) 73
hematopoietic stem cell transplantation (72) 72
animals (70) 70
medicine, research & experimental (68) 68
medicine & public health (66) 66
prognosis (59) 59
therapy (56) 56
care and treatment (55) 55
high-dose chemotherapy (55) 55
surgery (55) 55
leukemia (52) 52
rheumatology (52) 52
colony-stimulating factor (51) 51
hematopoietic stem cells (51) 51
analysis (50) 50
bone-marrow transplantation (49) 49
retrospective studies (49) 49
stem cells (49) 49
hematopoietic stem cells - cytology (48) 48
survival rate (48) 48
time factors (48) 48
survival (47) 47
research (46) 46
risk factors (45) 45
young adult (45) 45
cell biology (44) 44
combined modality therapy (42) 42
follow-up studies (42) 42
cisplatin (41) 41
multidisciplinary sciences (41) 41
antineoplastic combined chemotherapy protocols - adverse effects (40) 40
aged, 80 and over (38) 38
transplantation, homologous (38) 38
cells, cultured (36) 36
health aspects (35) 35
disease-free survival (34) 34
progenitor cells (34) 34
survival analysis (34) 34
diagnosis (33) 33
antineoplastic agents - therapeutic use (31) 31
bone-marrow (31) 31
disease (31) 31
etoposide (31) 31
hematopoietic stem cells - drug effects (31) 31
medicine, general & internal (31) 31
mice (31) 31
mortality (31) 31
hematopoietic stem cell transplantation - methods (30) 30
tumors (30) 30
antineoplastic combined chemotherapy protocols - administration & dosage (29) 29
dose-response relationship, drug (29) 29
acute myeloid-leukemia (28) 28
flow cytometry (28) 28
hematopoietic stem cells - immunology (28) 28
pharmacology & pharmacy (28) 28
risk (28) 28
in-vitro (27) 27
k ma hematology (27) 27
prospective studies (27) 27
testicular cancer (27) 27
cisplatin - administration & dosage (26) 26
patients (26) 26
bone marrow (25) 25
hematopoiesis (25) 25
ifosfamide - administration & dosage (25) 25
neoplasms - drug therapy (25) 25
testicular neoplasms - drug therapy (24) 24
transplantation, autologous (24) 24
abridged index medicus (23) 23
breast-cancer (23) 23
drug administration schedule (23) 23
germany (23) 23
germinoma - drug therapy (22) 22
hematopoietic stem cell transplantation - adverse effects (22) 22
etoposide - administration & dosage (21) 21
imatinib mesylate (21) 21
sensitivity and specificity (21) 21
transplantation conditioning - methods (21) 21
antineoplastic agents - adverse effects (20) 20
biotechnology & applied microbiology (20) 20
emergency medicine (20) 20
immunotherapy (20) 20
neoplasms - therapy (20) 20
relapse (20) 20
usage (20) 20
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1941) 1941
German (154) 154
French (22) 22
Chinese (1) 1
Latin (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Haematology, ISSN 0902-4441, 12/2016, Volume 97, Issue 6, pp. 517 - 527
Journal Article
Leukemia, ISSN 0887-6924, 11/2017, Volume 31, Issue 11, pp. 2398 - 2406
Journal Article
ONCOLOGY RESEARCH AND TREATMENT, ISSN 2296-5270, 09/2017, Volume 40, pp. 239 - 239
Conference Proceeding
by Rob, D and Špunda, R and Lindner, J and Šmalcová, J and Šmíd, O and Kovárník, T and Linhart, A and Bìlohlávek, J and Marinoni, M. M and Cianchi, G and Trapani, S and Migliaccio, M. L and Gucci, L and Bonizzoli, M and Cramaro, A and Cozzolino, M and Valente, S and Peris, A and Grins, E and Kort, E and Weiland, M and Shresta, N. Manandhar and Davidson, P and Algotsson, L and Fitch, S and Marco, G and Sturgill, J and Lee, S and Dickinson, M and Boeve, T and Khaghani, A and Wilton, P and Jovinge, S and Ahmad, A. N and Loveridge, R and Vlachos, S and Patel, S and Gelandt, E and Morgan, L and Butt, S and Whitehorne, M and Kakar, V and Park, C and Hayes, M and Willars, C and Hurst, T and Best, T and Vercueil, A and Auzinger, G and Adibelli, B and Akovali, N and Torgay, A and Zeyneloglu, P and Pirat, A and Kayhan, Z and Schmidbauer, S. S and Herlitz, J and Karlsson, T and Friberg, H and Knafelj, R and Radsel, P and Duprez, F and Bonus, T and Cuvelier, G and Mashayekhi, S and Maka, M and Ollieuz, S and Reychler, G and Mosaddegh, R and Abbasi, S and Talaee, S and Zotzmann, V. Z and Staudacher, D. S and Wengenmayer, T. W and Dürschmied, D. D and Bode, C. B and Nelskylä, A and Nurmi, J and Jousi, M and Schramko, A and Mervaala, E and Ristagno, G and Skrifvars, M and Ozsoy, G and Kendirli, T and Azapagasi, E and Perk, O and Gadirova, U and Ozcinar, E and Cakici, M and Baran, C and Durdu, S and Uysalel, A and Dogan, M and Ramoglu, M and Ucar, T and Tutar, E and Atalay, S and Akar, R and Kamps, M and ...
Critical Care, ISSN 1364-8535, 03/2017, Volume 21, Issue S1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 6, pp. 520 - 531
This international prospective study showed that maintenance therapy with rituximab was more effective than interferon alfa in prolonging the duration of... 
FCM | MEDICINE, GENERAL & INTERNAL | THERAPY | PROSPECTIVE RANDOMIZED-TRIAL | CYCLOPHOSPHAMIDE | PROGRESSION-FREE SURVIVAL | RITUXIMAB | CHRONIC LYMPHOCYTIC-LEUKEMIA | COMBINATION | FLUDARABINE | STUDY-GROUP GLSG | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Lymphoma, Mantle-Cell - mortality | Aged, 80 and over | Female | Maintenance Chemotherapy | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Survival Rate | Vidarabine - analogs & derivatives | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Vidarabine - administration & dosage | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Drugs | Dose-response relationship (Biochemistry) | Care and treatment | Fludarabine | Mantle cell lymphoma | Aged patients | Dosage and administration | Product/Service Evaluations | Drug therapy | Health aspects | Clinical trials | Prednisone | Lymphoma | Doxorubicin | Patients | Vincristine | α-Interferon | Cyclophosphamide | Motivation | Remission | Lymphomas | Computer centers | Age | Index Medicus | Abridged Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 05/2015, Volume 29, Issue 5, pp. 1123 - 1132
Journal Article
by Aoudjhane, M and Labopin, M and Gorin, N.C and Shimoni, A and Ruutu, T and Kolb, H.-J and Frassoni, F and Boiron, J.M and Yin, J.L and Finke, J and Shouten, H and Blaise, D and Falda, M and Fauser, A.A and Esteve, J and Polge, E and Slavin, S and Niederwieser, D and Nagler, A and Rocha, Vanderson and Galiene, P and Petrini, M and Schlimok, G and Buzyn, A and Ovali, E and Gratwohl, A and Willemze, R and Bunjes, D and Goldman, J.M and Jacobsen, N and Gluckman, E and Schanz, U and Boogaerts, M.A and Ljungman, P and Montserrat, E and Bron, D and Potter, M and Bacigalupo, A and Powles, R and Rio, B and Kanz, L and Goldstone, A.H and Remes, K and Greinix, H.T and Davies, J.M and Blaise, D and Falda, M and Mandelli, F and Cahn, J.Y and Ferrant, A and Brinch, L and Fernández-Ranada, J.M and Torres Gomez, A and Verdonck, L.F and Baccarani, M and Iriondo, A and Franklin, I and Rizzoli, V and Cornelissen, J.J and Van den Berg, H and Cordonnier, C and Harousseau, J.L and Barnard, D.L and Littlewood, T and Horst, H.A and McCann, S and Slavin, S and Schaefer, U.W and Sierra, J and Chapuis, B and Leblond, V and Guilhot, F and Lambertenghi Deliliers, G and Simonsson, B and Reiffers, J and Sotto, J.J and Gastl, G and Bay, J.O and Jackson, G.L and García-Conde, J and Lenhoff, S and Alessandrino, E.P and Majolino, I and Izzi, T and Brune, M and Pimentel, P and Siegert, W and Morra, E and Hertenstein, B and Hoelzer, D and Coser, P and Abecasis, M and Labar, B and Burnett, A.K and Bosi, A and Leone, G and Linkesch, W and Schwerdtfeger, R and Lauria, F and Acute Leukemia Working Party EBMT and Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
Leukemia, ISSN 0887-6924, 12/2005, Volume 19, Issue 12, pp. 2304 - 2312
Journal Article
EUROPEAN JOURNAL OF HORTICULTURAL SCIENCE, ISSN 1611-4426, 06/2009, Volume 74, Issue 3, pp. 130 - 136
Buxus sempervirens L. extant in a preserved renaissance parterre dating from ca. 1680 at Milde (Bergen, Norway) has been provisionally classified as the morphs... 
garden history | HORTICULTURE | conservation | renaissance garden | Norway | Buxus sempervirens cultivars | boxwood parterre
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1036 - 1047
Summary Background High-dose methotrexate is the standard of care for patients with newly diagnosed primary CNS lymphoma. The role of whole brain radiotherapy... 
Hematology, Oncology and Palliative Medicine | DEFERRED RADIOTHERAPY | 1ST-LINE TREATMENT | ONCOLOGY-GROUP | COMBINED-MODALITY THERAPY | ONCOLOGY | CONSOLIDATION RADIOTHERAPY | CELL TRANSPLANTATION | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | CHEMOTHERAPY | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Lymphoma - mortality | Antimetabolites, Antineoplastic - administration & dosage | Central Nervous System Neoplasms - radiotherapy | Lymphoma - drug therapy | Time Factors | Dose Fractionation | Female | Lymphoma - radiotherapy | Radiotherapy, Adjuvant | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Chi-Square Distribution | Cranial Irradiation - adverse effects | Cytarabine - administration & dosage | Disease-Free Survival | Methotrexate - adverse effects | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Methotrexate - administration & dosage | Aged | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Germany | Chemotherapy | Radiation | Product development | Lymphomas | Methotrexate | Radiotherapy | Biometry | Cancer
Journal Article
Journal Article